Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  CGC | T.WEED.DB

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.


TSX:WEED - Post by User

Comment by Newbie420on Feb 10, 2022 9:12am
72 Views
Post# 34415921

RE:RE:RE:RE:The reality is not bright for the future

RE:RE:RE:RE:The reality is not bright for the futureWant to know who this starsearcher character is. Read the following and see if he checks the boxes.

https://www.reddit.com/r/Superstonk/comments/mkos3f/analysis_research_of_paid_stock_bashers_same/

When the stock was down before the report you said the market was speaking and people are getting out. When it goes up after the report you don't say the market speaking but instead change the time frame until it agrees with your narrative. It's this kind of tactic that makes you deserving of the stock Basher label.

Starsearcher80 wrote: Ventura, as you said: "It really doesn't get anymore clear than what the screen says in front of you", as you noted the bump up today.

But the key word here is "today".  You're actually suggesting today provides the clarity that the company is doing fine?  Seriously?

Well let's take a look at more than just today.  Let's look out at something more representative, like the past 3 months.  Uh ohhhh.  The stock 3 months ago was $16.35.

Well let's take a look at more than just the past 3 months.  Let's look at the past year.  Uh ohhhhhhh!  The stock was north of $60.00???  And now it's $11.22???

Yes, I agree Ventura.  100%  It really doesn't get anymore clear than twhat the screen says in front of you!!



Ventura2020 wrote:

It really doesn't get anymore clear than what the screen says in front of you. 

CGC up 15.8% in the open market and at close. No matter what is said, it won't go up and it won't go down. 

Shorts want it to go down, Bulls want it to go up.

What is also clear, you are a short! That will never change! No one is looking to be saved, except maybe yourself.

Cheers,
V

 

 

Starsearcher80 wrote: Doesn't get any clearerthan that. Thanks Rotaluceps for the effort here to provide a concise synopsis. The numbers paint a grim reality for this company. The company, and the stock, remain untouchable.

 

Rotaluceps wrote:

As I often said, too many competitors. 


Net revenue of $141 million in Q3 FY2022 was a decline of 8% versus Q3 FY2021. Total global cannabis net revenue of $83 million in Q3 FY2022, represented a decline of 20% over Q3 FY2021. Other consumer products revenue of $58 million in Q3 FY2022, represented an increase of 19% over Q3 FY2021.  Excluding the impact from acquired businesses, net revenue declined 17% and global cannabis net revenue declined 34% versus Q3 FY2021.

Gross margin:

Reported gross margin in Q3 FY2022 was 7% as compared to 16% in Q3 FY2021. Excluding non-cash restructuring costs recorded in cost of goods sold and inventory step-up charges from acquisitions, adjusted gross margin was approximately 13%. Gross margin in Q3 FY2022 was further impacted by lower production output and price compression in the Canadian recreational business as well as higher third-party shipping, distribution and warehousing costs across North America. Gross margin in Q3 FY2022 benefited from payroll subsidies in the amount of $7 million received from the Canadian government, pursuant to a COVID-19 relief program.


 






<< Previous
Bullboard Posts
Next >>